
FRMSL — Investor Relations & Filings
Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 本公司製劑廠已通過衛生福利部GMP併GDP之評鑑 | 2022-06-21 | Chinese | |
| 110年企業ESG資訊揭露 | 2022-06-20 | Chinese | |
| 111年05月內部人持股異動(事後) | 2022-06-13 | Chinese | |
| 111年05月董事會成員及持股 | 2022-06-13 | Chinese | |
| 111年5月背書保證與資金貸與 | 2022-06-06 | Chinese | |
| 111年5月營業收入 | 2022-06-06 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 34616689 | 本公司製劑廠已通過衛生福利部GMP併GDP之評鑑 | 2022-06-21 | Chinese | ||
| 34616692 | 110年企業ESG資訊揭露 | 2022-06-20 | Chinese | ||
| 34616700 | 111年05月內部人持股異動(事後) | 2022-06-13 | Chinese | ||
| 34616695 | 111年05月董事會成員及持股 | 2022-06-13 | Chinese | ||
| 34616705 | 111年5月背書保證與資金貸與 | 2022-06-06 | Chinese | ||
| 34616702 | 111年5月營業收入 | 2022-06-06 | Chinese | ||
| 34616707 | 111年6月1日內部人設質解質 | 2022-06-02 | Chinese | ||
| 34616710 | 111年05月僑外投資持股 | 2022-05-18 | Chinese | ||
| 34616712 | 111年第1季海外子公司投資 | 2022-05-12 | Chinese | ||
| 34616714 | 111年第1季大陸投資 | 2022-05-12 | Chinese | ||
| 34616717 | 本公司認購子公司台新藥股份有限公司現金增資案, 交易金額達本公司實收資本額20%及新台幣3億元 | 2022-05-12 | Chinese | ||
| 34616719 | 公告本公司董事會決議設置公司治理主管 | 2022-05-12 | Chinese | ||
| 34616721 | 公告本公司董事會決議設置永續發展委員會 | 2022-05-12 | Chinese | ||
| 34616723 | 公告本公司提報董事會111年度第一季合併財務報告 | 2022-05-12 | Chinese | ||
| 34616735 | 111年第1季現金流量表 | 2022-05-12 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
FRMSL via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52425/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52425 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52425 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52425 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52425}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for FRMSL (id: 52425)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.